Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease

  title={Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease},
  author={Masatoshi Matsunami and Tomo Suzuki and Junko Fukuda and Toshiki Terao and Kohei Ukai and Shinnosuke Sugihara and Takumi Toishi and Kanako Nagaoka and Mayumi Nakata and Mamiko Ohara and Jun Yashima and Hiroshi Kuji and Kosei Matsue},
  journal={Renal Replacement Therapy},
Background Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of a COVID-19 vaccine. This study aimed to investigate the immune response to COVID-19 vaccination in patients with CKD stage G4 to G5 without renal replacement therapy and G5D using the recommended dose and schedule. Methods This retrospective single-center cohort study evaluated immunogenicity regarding antibody response after… 
1 Citations


Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
The immune response to SARS-CoV-2 vaccination among dialysis patients and kidney transplant recipients was evaluated, and the median S-IgG levels were significantly lower in the HD patients and KTx recipients compared with a control group.
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has posed a huge threat to global health because of its rapid spread and various mutant variants. Critical illness occurs in
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
The humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccines in this population of patients with kidney failure requiring maintenance dialysis were evaluated to evaluate the associations between vaccination and study outcomes.
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
This is the largest study to show in a well-characterized cohort that patients with higher GFR levels are more likely to respond to hepatitis B vaccination programs with seroconversion, independent of other factors.
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Protection against SARS-CoV-2 infection declined through August 2021 as the Delta variant emerged in the United States, and protection offered by the viral vector vaccine during the study declined to about 13% against infection and to about 50% against death.
Risk factors for severe and critically ill COVID‐19 patients: A review
In this review, the scientific evidence on the risk factors of severity of COVID‐19 are highlighted and socioeconomic status, diet, lifestyle, geographical differences, ethnicity, exposed viral load, day of initiation of treatment, and quality of health care have been reported to influence individual outcomes.
Covid-19: risk factors for severe disease and death
A long list is emerging from largely unadjusted analyses, with age near the top of the list of top 10 causes of death in the world of sport.